China Pharma Holdings (CPHI) Non Operating Income (2011 - 2026)
China Pharma Holdings (CPHI) reported Non Operating Income of -$25884.0 for Q1 2026, up 3.97% on a YoY basis from -$24895.7 in Q1 2025, and down 17.98% quarter-over-quarter from -$21940.0 in Q4 2025.
China Pharma Holdings (CPHI) Non Operating Income (2011 - 2026) Analysis & Trends
China Pharma Holdings has reported Non Operating Income for 16 years, with the latest figure at -$25884.0 in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income rose 3.97% year-over-year to -$25884.0; the trailing twelve-month figure through Mar 2026 stood at $52592.0 (up 139.07% YoY), and the FY2025 full-year result was $51522.0, up 134.93% from the prior year.
- Non Operating Income for Q1 2026 stood at -$25884.0, down from -$21940.0 in the prior quarter.
- The five-year high for Non Operating Income was $123753.0 in Q2 2025, with the low at -$136721.0 in Q2 2023.
- Historically, Non Operating Income has averaged -$51336.6 across 5 years, with a median of -$46609.0 in 2024.
- Annual changes were most pronounced in 2022 — Non Operating Income tumbled 66.21% — and 2025, when it jumped 365.51%.
- China Pharma Holdings' Non Operating Income stood at -$95172.0 in 2022, then surged by 49.86% to -$47722.0 in 2023, then soared by 40.5% to -$28396.0 in 2024, then climbed by 22.74% to -$21940.0 in 2025, then declined by 17.98% to -$25884.0 in 2026.
- The last three Non Operating Income figures came in at -$25884.0 (Q1 2026), -$21940.0 (Q4 2025), and -$23337.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 5.71 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -23.23 Mn |
| 10 | China Pharma Holdings | 19.13 Mn | 18.97 Mn | 285,487.00 | -25,884.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25,884.00 |
| Dec 31, 2025 | -21,940.00 |
| Sep 30, 2025 | -23,337.00 |
| Jun 30, 2025 | 123,753.00 |
| Mar 31, 2025 | -26,954.00 |
| Dec 31, 2024 | -28,396.00 |
| Sep 30, 2024 | -32,654.00 |
| Jun 30, 2024 | -46,609.00 |
| Mar 31, 2024 | -39,840.00 |
| Dec 31, 2023 | -47,722.00 |
| Sep 30, 2023 | -64,058.00 |
| Jun 30, 2023 | -136,721.00 |
| Mar 31, 2023 | -78,497.00 |
| Dec 31, 2022 | -95,172.00 |
| Sep 30, 2022 | -102,119.00 |
| Jun 30, 2022 | -108,801.00 |
| Mar 31, 2022 | -117,772.00 |
| Dec 31, 2021 | -332,029.00 |
| Sep 30, 2021 | -64,265.00 |
| Jun 30, 2021 | -71,813.00 |